This week the Health Research Authority and National Institute for Health Research jointly published a report of the general public's attitudes towards health research.
The HRA and the NIHR commissioned Ipsos MORI to conduct a general public omnibus survey in 2017. They interviewed 1,014 adults across England, Scotland and Wales to understand the range of opinions held by the public about health research and found that 83% of respondents said that health research is very important.
The report, and its scrutiny of the work the ABPI and our members are doing to improve the reputation of our industry, is important and highlights the progress we are making in improving trust and reputation.
From Disclosure UK – the open database of payments and benefits in kind received by healthcare professionals and organisations from our industry – to working with the NHS on developing robust conflict of interest guidance, we are committed to improving what people think about our industry and the medicines we develop and launch.
Recent data shows that timely reporting of results from pharmaceutical company-sponsored clinical trials for newly approved medicines has reached the highest recorded level of 93%, with the MHRA receiving 804 applications for commercial clinical trials in 2016.
We believe the best way to research, develop and deliver new, life-changing medicines is in partnership with the NHS and NIHR Clinical Research, and we will continue to do so in the interests of the millions of patients across the UK who rely on them.